Teollisuuden Voima Oyj:企業の戦略的SWOT分析

◆英語タイトル:Teollisuuden Voima Oyj - Strategic SWOT Analysis Review
◆商品コード:DATA904C4846
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:電力
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Teollisuuden Voima Oyj – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Teollisuuden Voima Oyj (TVO), a subsidiary of Pohjolan Voima Oy, is a power company that generates and supplies electricity. It generates electricity primarily at its nuclear power plants. The company holds interest in two nuclear power plants at Olkiluoto, a gas turbine plant, and a wind power plant in Olkiluoto. Its generation portfolio also includes a wind power facility, a coal-fired power generation plant and a turbine reserve power plant. It also conducts research and development activities in the areas of nuclear energy technology, environmental and nuclear waste, and safety at its plants. The company supplies the electricity it produces to industries and energy utilities in Finland. The company has offices in Eurajoki, Helsinki and Pori. TVO is headquartered in Eurajoki, Finland.

Teollisuuden Voima Oyj Key Recent Developments

Apr 03,2018: White & Case Advises TVO on Global Settlement Agreement
Mar 13,2018: Caverion and Teollisuuden Voima continue their long-term maintenance cooperation
Mar 11,2018: TVO confirms agreement on Olkiluoto 3 project completion and related disputes
Mar 06,2018: Change in senior management at TVO
Oct 23,2017: Teollisuuden Voima Oyj’s Interim Report January 1–September 30, 2017

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Teollisuuden Voima Oyj – Key Facts 5
Teollisuuden Voima Oyj – Key Employees 6
Teollisuuden Voima Oyj – Key Employee Biographies 7
Teollisuuden Voima Oyj – Major Products and Services 8
Teollisuuden Voima Oyj – History 9
Teollisuuden Voima Oyj – Company Statement 11
Teollisuuden Voima Oyj – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Joint Venture 13
Section 2 – Company Analysis 15
Company Overview 15
Teollisuuden Voima Oyj – Business Description 16
Teollisuuden Voima Oyj – Corporate Strategy 17
Teollisuuden Voima Oyj – SWOT Analysis 18
SWOT Analysis – Overview 18
Teollisuuden Voima Oyj – Strengths 18
Teollisuuden Voima Oyj – Weaknesses 19
Teollisuuden Voima Oyj – Opportunities 20
Teollisuuden Voima Oyj – Threats 21
Teollisuuden Voima Oyj – Key Competitors 22
Section 3 – Company’s Power Financial Deals and Alliances 23
Teollisuuden Voima Oyj, Power, Deals By Year, 2012 to YTD 2018 23
Teollisuuden Voima Oyj, Power, Deals By Type, 2012 to YTD 2018 24
Teollisuuden Voima Oyj, Recent Deals Summary 25
Section 4 – Company’s Recent Developments 26
Apr 03, 2018: White & Case Advises TVO on Global Settlement Agreement 26
Mar 06, 2018: Change in senior management at TVO 27
Oct 23, 2017: Teollisuuden Voima Oyj’s Interim Report January 1–September 30, 2017 28
Jul 21, 2017: Teollisuuden Voima Oyj’s Interim Report January 1–June 30, 2017 30
Jul 20, 2017: Teollisuuden Voima: Partial award granted in ICC arbitration concerning the delay of Olkiluoto 3 EPR project 38
Jul 18, 2017: Annual outages completed at Olkiluoto nuclear power plant 39
Jun 14, 2017: OL2′s annual maintenance is prolonged 40
Jun 12, 2017: Olkiluoto 3 EPR project reaches cold functional test stage 41
May 29, 2017: TVO withdraws its summary proceedings against AREVA 42
May 10, 2017: TVO submitted Le Creusot report to STUK 43
Section 5 – Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Teollisuuden Voima Oyj, Key Facts 5
Teollisuuden Voima Oyj, Key Employees 6
Teollisuuden Voima Oyj, Key Employee Biographies 7
Teollisuuden Voima Oyj, Major Products and Services 8
Teollisuuden Voima Oyj, History 9
Teollisuuden Voima Oyj, Other Locations 13
Teollisuuden Voima Oyj, Subsidiaries 13
Teollisuuden Voima Oyj, Joint Venture 13
Teollisuuden Voima Oyj, Key Competitors 22
Teollisuuden Voima Oyj, Power, Deals By Year, 2012 to YTD 2018 23
Teollisuuden Voima Oyj, Power, Deals By Type, 2012 to YTD 2018 24
Teollisuuden Voima Oyj, Recent Deals Summary 25

List of Figures
Teollisuuden Voima Oyj, Power, Deals By Year, 2012 to YTD 2018 23
Teollisuuden Voima Oyj, Power, Deals by Type, 2012 to YTD 2018 24

★海外企業調査レポート[Teollisuuden Voima Oyj:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Vanguard Group Inc:企業の戦略的SWOT分析
    The Vanguard Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Camping World Holdings, Inc. (CWH):企業の財務・戦略的SWOT分析
    Camping World Holdings, Inc. (CWH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cytori Therapeutics Inc (CYTX):医療機器:M&Aディール及び事業提携情報
    Summary Cytori Therapeutics Inc (Cytori) is a clinical stage cell therapy company. It develops cell therapies from autologous adipose-derived regenerative cells (ADRCs) for the treatment of cardiovascular disease, orthopedic conditions and gastrointestinal disorders. The company has two therapeutic …
  • Nymox Pharmaceutical Corp (NYMX):企業の財務・戦略的SWOT分析
    Nymox Pharmaceutical Corp (NYMX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • GLG Life Tech Corp (GLG):企業の財務・戦略的SWOT分析
    GLG Life Tech Corp (GLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Biosense Webster Inc:医療機器:M&Aディール及び事業提携情報
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac …
  • Exor N.V:企業の戦略・SWOT・財務分析
    Exor N.V - Strategy, SWOT and Corporate Finance Report Summary Exor N.V - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • GW Pharmaceuticals Plc (GWP):医療機器:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Izumi Co., Ltd.:戦略・SWOT・企業財務分析
    Izumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Izumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Crescita Therapeutics Inc (CTX):企業の財務・戦略的SWOT分析
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) operates as a commercial dermatology company that offers prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. The company’s products comprise Pliaglis, Alyria, Laboratoire Dr Renaud, Pro-De …
  • Isagenix International LLC:企業の戦略的SWOT分析
    Isagenix International LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • NuSirt Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NuSirt Biopharma Inc (NuSirt Sciences) develops a technology platform that combines natural compounds with various pharmaceutical agents to prevent and treat chronic diseases resulting from over-nutrition and aging. Its technology platform focuses on activating sirtuin pathways through the a …
  • Crescita Therapeutics Inc (CTX)-製薬・医療分野:企業M&A・提携分析
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) develops products for the treatment of skin diseases and their symptoms. The company’s product portfolio includes over-the-counter and prescription products such as topical creams. It offers pliaglis, a local anesthetic cream for superficial …
  • Nippon Flour Mills Co Ltd (2001):企業の財務・戦略的SWOT分析
    Nippon Flour Mills Co Ltd (2001) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Renk AG (ZAR):企業の財務・戦略的SWOT分析
    Renk AG (ZAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Cadila Healthcare Ltd (CADILAHC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cadila Healthcare Ltd (Zydus Cadila) is an integrated, global healthcare provider. It discovers, develops, manufactures and markets various healthcare products. The company’s product portfolio includes active pharmaceutical ingredients (APIs), formulations, wellness and animal health product …
  • People’S Bank
    People'S Bank - Strategy, SWOT and Corporate Finance Report Summary People'S Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kuwait Food Company (Americana) KSCP:企業の戦略的SWOT分析
    Kuwait Food Company (Americana) KSCP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Sutter Health:企業の戦略的SWOT分析
    Sutter Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Hess Corporation:企業の戦略・SWOT・財務情報
    Hess Corporation - Strategy, SWOT and Corporate Finance Report Summary Hess Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆